Sara Bolin

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Dna Damage Response

Top Venues

Science signaling

Cancer research

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Borgenvik, Karl O Holmberg, Sara Bolin, Miao Zhao, Vasil Savov, Gabriela Rosén, Sonja Hutter, Alexandra Garancher, Aldwin Suryo Rahmanto, Tobias Bergström, Thale Kristin Olsen, Oliver J Mainwaring, Damiana Sattanino, Annemieke D Verbaan, Jessica M Rusert, Anders Sundström, Mar Ballester Bravo, Yonglong Dang, Amelie S Wenz, Stacey Richardson, Grammatiki Fotaki, Rebecca M Hill, Adrian M Dubuc, Antonia Kalushkova, Marc Remke, Matko Čančer, Helena Jernberg-Wiklund, Géraldine Giraud, Xingqi Chen, Michael D Taylor, Olle Sangfelt, Steven C Clifford, Ulrich Schüller, Robert J Wechsler-Reya, Holger Weishaupt, Fredrik J Swartling
Dormant SOX9-positive cells facilitate MYC-driven recurrence of medulloblastoma. Cancer research (2022)
Laura M Prolo, Amy Li, Scott F Owen, Jonathon J Parker, Kara Foshay, Ryan T Nitta, David W Morgens, Sara Bolin, Christy M Wilson, Johana C M Vega L, Emily J Luo, Gigi Nwagbo, Allen Waziri, Gordon Li, Richard J Reimer, Michael C Bassik, Gerald A Grant
Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion. Scientific reports 9 (1) (2019)
Ryan T Nitta, Sara Bolin, Emily Luo, David E Solow-Codero, Peyman Samghabadi, Teresa Purzner, Parvir S Aujla, Ginikachi Nwagbo, Yoon-Jae Cho, Gordon Li
Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene 38 (42) (2019)
Matko Čančer, Lisa F Drews, Johan Bengtsson, Sara Bolin, Gabriela Rosén, Bengt Westermark, Sven Nelander, Karin Forsberg-Nilsson, Lene Uhrbom, Holger Weishaupt, Fredrik J Swartling
BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells. Cell death & disease 10 (12) (2019)
Teresa Purzner, James Purzner, Taylor Buckstaff, Giorgio Cozza, Sharareh Gholamin, Jessica M Rusert, Tom A Hartl, John Sanders, Nicholas Conley, Xuecai Ge, Marc Langan, Vijay Ramaswamy, Lauren Ellis, Ulrike Litzenburger, Sara Bolin, Johanna Theruvath, Ryan Nitta, Lin Qi, Xiao-Nan Li, Gordon Li, Michael D Taylor, Robert J Wechsler-Reya, Lorenzo A Pinna, Yoon-Jae Cho, Margaret T Fuller, Joshua E Elias, Matthew P Scott
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. Science signaling 11 (547) (2018)